Corestreet Logo

Crispr Therapeutics AG (CRSP) Insider Trading

Total insider buys:
  • $27,833,805.86
Total insider sells:
  • $313,185,058.53
Most recent insider trade:
  • April 15, 2024
Most active insider trader:
  • Samarth Kulkarni
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 27, 2017Director200$20.24Sell$4,048.00
Nov. 24, 2017Director1,700$20.21Sell$34,357.00
Nov. 24, 2017Major Shareholder26,010$20.00Sell$520,200.00
Nov. 22, 2017Major Shareholder256,000$19.76Sell$5,058,560.00
Nov. 20, 2017Major Shareholder158,718$19.02Sell$3,018,816.36
Nov. 17, 2017Major Shareholder51,282$18.44Sell$945,640.08
Nov. 15, 2017Major Shareholder15,000$17.67Sell$265,050.00
Nov. 13, 2017Major Shareholder65,093$17.76Sell$1,156,051.68
Nov. 10, 2017Major Shareholder10,000$17.28Sell$172,800.00
Nov. 8, 2017Major Shareholder16,875$18.06Sell$304,762.50
Nov. 6, 2017Major Shareholder79,327$18.89Sell$1,498,487.03
Nov. 3, 2017Major Shareholder22,759$19.10Sell$434,696.90
Sept. 5, 2017CEO18,470$20.76Sell$383,437.20
Aug. 30, 2017Insider27,154$20.08Sell$545,252.32
Aug. 30, 2017CEO75,795$20.25Sell$1,534,848.75
Aug. 28, 2017Director88,011$19.79Sell$1,741,737.69
Aug. 25, 2017Director22,781$19.42Sell$442,407.02
Aug. 23, 2017Director17,989$18.53Sell$333,336.17
Aug. 21, 2017Director3,150$18.52Sell$58,338.00
Aug. 17, 2017Director34,141$19.06Sell$650,727.46
Aug. 15, 2017Director55,569$19.59Sell$1,088,596.71
Aug. 8, 2017Director35,473$18.63Sell$660,861.99
Aug. 8, 2017Insider15,000$18.57Sell$278,550.00
Aug. 4, 2017Director50,477$17.81Sell$898,995.37
Aug. 1, 2017Director5,512$17.51Sell$96,515.12
July 28, 2017Director41,312$17.63Sell$728,330.56
July 26, 2017Director32,930$17.60Sell$579,568.00
July 14, 2017Director69,859$16.84Sell$1,176,425.56
July 12, 2017Director31,992$16.56Sell$529,787.52
July 5, 2017Director4,254$16.26Sell$69,170.04
June 29, 2017Director43,202$16.90Sell$730,113.80
June 27, 2017Director81,435$17.08Sell$1,390,909.80
June 23, 2017Director32,368$16.23Sell$525,332.64
June 22, 2017CEO10,825$15.37Sell$166,380.25
June 21, 2017CEO30,222$15.01Sell$453,632.22
June 9, 2017CEO5,303$15.02Sell$79,651.06
May 30, 2017CEO3,650$15.02Sell$54,823.00
May 17, 2017CEO50,000$16.26Sell$813,000.00
May 5, 2017CEO616$16.92Sell$10,422.72
May 4, 2017CEO49,384$16.30Sell$804,959.20
April 28, 2017Insider21,639$16.78Sell$363,102.42
April 27, 2017Insider5,481$16.76Sell$91,861.56
April 25, 2017Insider11,615$16.78Sell$194,899.70
April 20, 2017Insider10,177$17.71Sell$180,234.67
April 20, 2017CEO50,000$17.88Sell$894,000.00
Oct. 24, 2016Director66,500$14.00Buy$931,000.00
Oct. 24, 2016Major Shareholder800,150$14.00Buy$11,202,100.00
First«3 of 3»Last

  • Insiders are both buying and selling Crispr Therapeutics AG stock.

  • The insider traders at Crispr Therapeutics AG are: Samarth Kulkarni, Rodger Novak, Kurt Von Emster, Bradley J Phd Bolzon, Corp /De/ Celgene, Tyler Dylan-Hyde, Pablo J Cagnoni, Lawrence Otto Klein, Thomas Woiwode, Vertex Pharmaceuticals (Europe, Michael John Tomsicek, James R Kasinger, Raju Prasad, Bradley J. Phd Bolzon, James R. Kasinger, Aktiengesellschaft Bayer, Simeon George, Tony W Ho, Tony W. Ho, and Versant Venture Capital V, L.P

  • The most active insider trader at Crispr Therapeutics AG is Samarth Kulkarni with 31 trades.

  • Kurt Von Emster has sold the most Crispr Therapeutics AG stock with a total value of $68,130,025.01.

  • Aktiengesellschaft Bayer has bought the most Crispr Therapeutics AG stock with a total value of $23,999,976.00.

  • The most recent insider trade for Crispr Therapeutics AG was on April 15, 2024.

  • The single biggest insider buy for Crispr Therapeutics AG was from Aktiengesellschaft Bayer with a total value of $11,999,988.00 on Jan. 5, 2018.

  • The single biggest insider sell for Crispr Therapeutics AG was from Kurt Von Emster with a total value of $35,353,500.00 on May 14, 2018.